GleamWall
中文EN

VRCA Verrica Pharmaceuticals Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1660334 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY370.2%
TTM net income YoY76.6%
TTM EPS YoY88.6%
Revenue 3-yr CAGR57.9%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-34.2%
Net margin-50.3%
FCF margin—
EBITDA margin-33.9%

Returns

ROE-240.4%
ROA-35.3%
ROIC (approx.)—
Asset turnover0.70x

Leverage & solvency

Liabilities / assets47.5%
Debt / equity0.00x
Current ratio2.59x
Interest coverage-1.57x

Cash quality & payout

Operating cash flow / net income0.99x
Accruals ratio-0.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$35.58M$7.57M
Cost of revenue—$2.60M
Gross profit—$4.97M
R&D expense$8.86M$11.84M
SG&A expense$35.22M$58.82M
Operating income-$12.19M-$65.92M
Interest expense$7.74M$9.41M
Income tax$0$0
Net income-$17.89M-$76.58M
EBITDA-$12.05M-$65.58M
EPS (basic)-1.68-14.78
EPS (diluted)-1.68-14.78
Weighted avg. shares (diluted)10.65M5.18M
Balance sheet
Cash & equivalents$30.15M$46.33M
Receivables$5.26M$48,000
Inventory$2.24M$2.46M
Current assets$42.54M$51.18M
PP&E, net$209,000$589,000
Total assets$47.13M$54.13M
Current liabilities$16.44M$29.01M
Short-term debt$0$12.94M
Long-term debt$0$30.98M
Total debt$0$43.92M
Total liabilities$22.39M$63.99M
Shareholders' equity$24.74M-$9.86M
Net debt-$30.15M-$2.41M
Shares outstanding17.18M9.18M
Cash flow statement
Operating cash flow-$17.63M-$60.93M
Capital expenditure$0$27,000
Free cash flow-$17.63M-$60.95M
Investing cash flow$0-$19,000
Financing cash flow$1.45M$37.73M
Depreciation & amortization$133,000$342,000
Stock-based compensation$3.32M$7.16M

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.